$1.9 - IPHA | Innate Pharma S.A. ADS

Innate Pharma S.A. ADS (IPHA)

Innate Pharma S.A. ADS

XNAS:IPHA

1.9

-2.56%

Ask

$1.96 - 1,000.00

Bid

$1.72 - 1.00

Low

$1.93

High

$2.01

Open

$1.93

Prev Close

$1.95

52W High

3.51

52W Low

1.41

Volume

31554

Avg Vol (3m)

26653.1

Float

Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 389
0

Chart

TendieTensor AI Analysis

Company

Asset Type: American Depository Receipt Common

SIC Code:

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 09/09/2015

Primary Exchange: XNAS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

174

P/E (TTM)

-3.180000

P/B (TTM)

29.761900

Round Lot

100

Composit FIGI

BBG009ZCBVG7

Share Class FIGI

BBG009ZCBWH4

Share Class Shares Outstanding

92.18M

Weighted Shares Outstanding

92.17M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion